Zymeworks Inc. Reports Q2 2026 Financial Results

What Happened

• Zymeworks issued a press release dated August 6, 2026 announcing its financial results for the three months ended June 30, 2026; that press release is attached as Exhibit 99.1 to the Form 8‑K (filed under Item 2.02). The company also provided Regulation FD disclosure about how it communicates material information to the public (Item 7.01).

Key Details

• Press release reporting quarterly results: dated August 6, 2026 and attached as Exhibit 99.1.
• Period covered: three months ended June 30, 2026 (quarterly results / earnings).
• Public disclosure channels named: SEC filings, press releases, public conference calls, company website (www.zymeworks.com), investor sites (ir.zymeworks.com), publications/events pages, X (@ZymeworksInc) and LinkedIn.
• Legal note: the information furnished under Items 2.02 and 7.01 is "furnished" (not "filed") and therefore is not subject to Section 18 liability or automatically incorporated by reference into other filings.

Why It Matters

• This 8‑K signals that Zymeworks has released its latest quarterly results; investors should review the attached press release for specifics on revenue, earnings, cash position, and any updated guidance or operational commentary. The company’s statement about its disclosure channels is a reminder to monitor its website, SEC filings, and social media for timely material updates. Finally, the filing’s legal note clarifies the limited liability and incorporation status of the furnished information.